Meeting
2011 ASCO Annual Meeting
Molecular studies support the association between germ-line genetic variants in the vascular endothelial growth factor (VEGF) pathway and survival in non-small cell lung cancer (NSCLC) patients.
Authors
D. M. Glubb
University of North Carolina at Chapel Hill, Chapel Hill, NC
D. M. Glubb , W. Zhang , K. Owzar , C. Jiang , O. Mirza , S. Kashyap , W. Rzyman , J. Jassem , F. R. Hirsch , R. Dziadziuszko , F. Innocenti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell
Track
Lung Cancer
Sub Track
Local-Regional Therapy
Citation
J Clin Oncol 29: 2011 (suppl; abstr 7059)
Abstract #
7059
Poster Bd #
23G
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Comparison between circulating tumor DNA and tumor tissue multiple gene detection in non-small cell lung cancer patients by targeted sequencing with the Ion PGM and AmpliSeq Cancer Panel.
First Author: Fan Yang
Poster
2016 Gastrointestinal Cancers Symposium
Phase II study of dovitinib in patients (Pts) progressing on anti-vascular endothelial growth factor (VEGF) therapy.
First Author: Thomas John Semrad
Poster
2015 Gastrointestinal Cancers Symposium
Mutational Analysis of clinically relevant cancer related genes in colorectal cancer.
First Author: Aine O'Reilly
Poster
2011 ASCO Annual Meeting
The predictive value of single nucleotide polymorphisms in the vascular endothelial growth factor system in patients with metastatic colorectal cancer treated with bevacizumab plus chemotherapy as first-line treatment: Results of the phase III ACT trial NCT00598156 translational study.
First Author: T. Hansen